De novo generation of prion strains

Nature Reviews Microbiology

Volumn 9, Issue 11, 2011, Pages 771-777

  Colby, David W ^a   Prusiner, Stanley B ^b  

^a University of Delaware   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ARTICLE; BIOASSAY; CELL FREE SYSTEM; IN VITRO STUDY; NONHUMAN; PRION; PRIORITY JOURNAL; ULTRASOUND; VIRUS STRAIN;

ANIMALS; CRICETINAE; ESCHERICHIA COLI; MICE; MODELS, MOLECULAR; PRIONS; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS;

BOVINAE;

EID: 80054745655     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro2650     Document Type: Article

References (69)

1. Colby, D. W. & Prusiner, S. B. Prions. Cold Spring Harb. Perspect. Biol. 3, a006833 (2011).
2. Legname, G. et al. Synthetic mammalian prions. Science 305, 673-676 (2004). (Pubitemid 39006757)
3. Colby, D. W. et al. Protease-sensitive synthetic prions. PLoS Pathog. 6, e1000736 (2010).
4. Wang, F., Wang, X., Yuan, C.-G. & Ma, J. Generating a prion with bacterially expressed recombinant prion protein. Science 327, 1132-1135 (2010).
5. Colby, D. W. et al. Design and construction of diverse mammalian prion strains. Proc. Natl Acad. Sci. USA 106, 20417-20422 (2009).
6. Makarava, N. et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol. 119, 177-187 (2010).
7. Barria, M. A., Mukherjee, A., Gonzalez-Romero, D., Morales, R. & Soto, C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog. 5, e1000421 (2009).
8. Deleault, N. R., Harris, B. T., Rees, J. R. & Supattapone, S. Formation of native prions from minimal components in vitro. Proc. Natl Acad. Sci. USA 104, 9741-9746 (2007). (Pubitemid 47175337)
9. Pattison, I. H. & Millson, G. C. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J. Comp. Pathol. 71, 101-108 (1961).
10. Prusiner, S. B. Molecular biology of prion diseases. Science 252, 1515-1522 (1991). (Pubitemid 21917065)
11. Bessen, R. A. & Marsh, R. F. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 66, 2096-2101 (1992).
12. Telling, G. C. et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274, 2079-2082 (1996). (Pubitemid 27020700)
13. Legname, G. et al. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl Acad. Sci. USA 103, 19105-19110 (2006). (Pubitemid 350002835)
14. Wickner, R. B. [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566-569 (1994). (Pubitemid 24185861)
15. Patino, M. M., Liu, J.-J., Glover, J. R. & Lindquist, S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273, 622-626 (1996). (Pubitemid 26262109)
16. Tanaka, M., Chien, P., Naber, N., Cooke, R. & Weissman, J. S. Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323-328 (2004). (Pubitemid 38418803)
17. Tanaka, M., Collins, S. R., Toyama, B. H. & Weissman, J. S. The physical basis of how prion conformations determine strain phenotypes. Nature 442, 585-589 (2006). (Pubitemid 44167919)
18. Derkatch, I. L., Chernoff, Y. O., Kushnirov, V. V., Inge-Vechtomov, S. G. & Liebman, S. W. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144, 1375-1386 (1996). (Pubitemid 26427888)
19. Speransky, V. V., Taylor, K. L., Edskes, H. K., Wickner, R. B. & Steven, A. C. Prion filament networks in [URE3] cells of Saccharomyces cerevisiae. J. Cell Biol. 153, 1327-1336 (2001).
20. Tessier, P. M. & Lindquist, S. Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 447, 556-561 (2007). (Pubitemid 46868043)
21. Wille, H., Baldwin, M. A., Cohen, F. E., DeArmond, S. J. & Prusiner, S. B. in CIBA Foundation Symposium No. 199: The Nature and Origins of Amyloid Fibrils. 181-201 (John Wiley & Sons, Chichester, 1996).
22. Colby, D. W. et al. Prion detection by an amyloid seeding assay. Proc. Natl Acad. Sci. USA 104, 20914-20919 (2007).
23. King, C. Y. & Diaz-Avalos, R. Protein-only transmission of three yeast prion strains. Nature 428, 319-323 (2004). (Pubitemid 38418802)
24. Kocisko, D. A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471-474 (1994). (Pubitemid 24263553)
25. Castilla, J., Saa, P., Hetz, C. & Soto, C. In vitro generation of infectious scrapie prions. Cell 121, 195-206 (2005). (Pubitemid 40546388)
26. Hsiao, K. K. et al. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250, 1587-1590 (1990). (Pubitemid 120034374)
27. Kaneko, K. et al. A synthetic peptide initiates Gerstmann- Sträussler-Scheinker (GSS) disease in transgenic mice. J. Mol. Biol. 295, 997-1007 (2000).
28. Sc conformers induced by a synthetic peptide and several prion strains. J. Virol. 78, 2088-2099 (2004). (Pubitemid 38176741)
29. Legname, G. et al. Strain-specified characteristics of mouse synthetic prions. Proc. Natl Acad. Sci. USA 102, 2168-2173 (2005). (Pubitemid 40262030)
30. Gambetti, P. et al. A novel human disease with abnormal prion protein sensitive to protease. Ann. Neurol. 63, 697-708 (2008). (Pubitemid 351945529)
31. Ayers, J. I. et al. The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog. 7, e1001317 (2011).
32. McKinley, M. P., Bolton, D. C. & Prusiner, S. B. A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62 (1983). (Pubitemid 14240218)
33. May, B. C. H., Govaerts, C., Prusiner, S. B. & Cohen, F. E. Prions: So many fibers, so little infectivity. Trends Biochem. Sci. 29, 162-165 (2004). (Pubitemid 38472018)
34. Kimberlin, R. & Walker, C. Characteristics of a short incubation model of scrapie in the golden hamster. J. Gen. Virol. 34, 295-304 (1977). (Pubitemid 8028621)
35. Kim, J. I. et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J. Biol. Chem. 285, 14083-14087 (2010).
36. Piening, N., Weber, P., Giese, A. & Kretzschmar, H. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein. Biochem. Biophys. Res. Commun. 326, 339-343 (2005). (Pubitemid 39593552)
37. Flint, E. B. & Suslick, K. S. The temperature of cavitation. Science 253, 1397-1399 (1991). (Pubitemid 21917288)
38. Mark, G. et al. OH-radical formation by ultrasound in aqueous solution - Part II: Terephthalate and Fricke dosimetry and the influence of various conditions on the sonolytic yield. Ultrason. Sonochem. 5, 41-52 (1998).
39. Stathopulos, P. B. et al. Sonication of proteins causes formation of aggregates that resemble amyloid. Protein Sci. 13, 3017-3027 (2004). (Pubitemid 39431263)
40. Price, G. J. & Smith, P. F. Ultrasonic degradation of polymer solutions: 2. The effect of temperature, ultrasound intensity and dissolved gases on polystyrene in toluene. Polymer 34, 4111-4117 (1993).
41. Meyer-Luehmann, M. et al. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313, 1781-1784 (2006). (Pubitemid 44454153)
42. Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Med. 14, 501-503 (2008).
43. Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B. & Olanow, C. W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nature Med. 14, 504-506 (2008). (Pubitemid 351655212)
44. Prusiner, S. B. et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349-358 (1983). (Pubitemid 14202913)
45. Glenner, G. G. & Wong, C. W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890 (1984). (Pubitemid 14104991)
46. Masters, C. L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 4245-4249 (1985). (Pubitemid 15053619)
47. Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706 (1991). (Pubitemid 21912142)
48. Hardt, F. & Ranlov, P. Transfer amyloidosis. Int. Rev. Exp. Pathol. 16, 273-334 (1976).
49. Axelrad, M. A., Kisilevsky, R., Willmer, J., Chen, S. J. & Skinner, M. Further characterization of amyloid-enhancing factor. Lab. Invest. 47, 139-146 (1982). (Pubitemid 12051536)
50. Ganowiak, K., Hultman, P., Engstrom, U., Gustavsson, A. & Westermark, P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem. Biophys. Res. Commun. 199, 306-312 (1994). (Pubitemid 24179949)
51. Geula, C. et al. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med. 4, 827-831 (1998). (Pubitemid 28331025)
52. Gotz, J., Chen, F., van Dorpe, J. & Nitsch, R. M. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ 42 fibrils. Science 293, 1491-1495 (2001). (Pubitemid 32807681)
53. Perutz, M. F. & Windle, A. H. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats. Nature 412, 143-144 (2001). (Pubitemid 32674702)
54. Frost, B., Jacks, R.L. & Diamond, M.I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845-12852 (2009).
55. Lee, H.-J. et al. Assembly-dependent endocytosis and clearance of extracellular α-synuclein. Int. J. Biochem. Cell Biol. 40, 1835-1849 (2008).
56. Yang, W., Dunlap, J. R., Andrews, R. B. & Wetzel, R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11, 2905-2917 (2002).
57. Ren, P. H. et al. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nature Cell Biol. 11, 219-225 (2009).
58. Sung, J. Y. et al. Induction of neuronal cell death by Rab5A-dependent endocytosis of α-synuclein. J. Biol. Chem. 276, 27441-27448 (2001).
59. Desplats, P. et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl Acad. Sci. USA 106, 13010-13015 (2009).
60. Truant, R., Atwal, R. S., Desmond, C., Munsie, L. & Tran, T. Huntington's disease: Revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases. FEBS J. 275, 4252-4262 (2008).
61. Nelson, R. et al. Structure of the cross-β spine of amyloid-like fibrils. Nature 435, 773-778 (2005). (Pubitemid 40839722)
62. Wasmer, C. et al. Amyloid fibrils of the HET-s(218-289) prion form a β solenoid with a triangular hydrophobic core. Science 319, 1523-1526 (2008). (Pubitemid 351398180)
63. Toyama, B. H., Kelly, M. J., Gross, J. D. & Weissman, J. S. The structural basis of yeast prion strain variants. Nature 449, 233-237 (2007). (Pubitemid 47402368)
64. Wille, H. et al. Natural and synthetic prion structure from X-ray fiber diffraction. Proc. Natl Acad. Sci. USA 106, 16990-16995 (2009).
65. Shorter, J. & Lindquist, S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304, 1793-1797 (2004). (Pubitemid 38787894)
66. Telling, G. C. et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90 (1995).
67. Cello, J., Paul, A. V. & Wimmer, E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297, 1016-1018 (2002). (Pubitemid 34856035)
68. Kornberg, A. & Baker, T. A. DNA Replication (W. H. Freeman, New York, 1992).
69. Saborio, G. P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813 (2001). (Pubitemid 32588105)